North Valley Neurology & Sleep

North Valley Neurology & Sleep © All Rights Reserved.  

Looking After Your Health
Welcome.

Dr. Gitt.

Dr. Mussomeli.

Mgr/MS Nurse.

Office Staff.

Alzheimer’s.

Botox.

Clinical/Drug Trials.

EMG & NCV.

Multiple Sclerosis.

Legistlation/News.

Sleep Disorders.

Contact.

Insurance.

Links.

3815 E. Bell Rd. #2400
Phoenix, AZ
85032
Phone: (602) 482-2116

FAX: (602) 482-9563

Treatment of Multiple Sclerosis

Currently there are 7 approved therapies for treatment of MS:
Ÿ
Avonex (Interferon beta-1a), which is an intramuscular injection given once a week.
Ÿ
Rebif (Interferon beta-1a), which is a subcutaneous injection given three times a week.
Ÿ
Betaseron (Interferon beta-1b), which is a subcutaneous injection given every other day.
Ÿ
Extavia (Interferon B-1b).
Ÿ
Copaxone (Glatiramir Acetate), which is a subcutaneous injection given daily.
Ÿ
Gilenya-The first approved oral disease modifying drug to treat relapsing forms of MS

These four products are approved for relapsing forms of MS, and are the most common first treatment options for patients with MS.

Ÿ
Tysabri (Natalizumab), which is an intravenous infusion given every four weeks. This drug is for patients with relapsing forms of MS who have failed other therapies, or, are intolerant to other therapies.
Ÿ
Novantrone (Mitoxantrone), which is a chemotherapy drug given intravenously every 3 months. This drug is for patients with secondary progressive MS.
Ÿ
Ampyra, This is a new drug just approved that improves speed of walking and reduces spasticity in patients with MS.

These drugs are all used to try to slow down the progression of the disease. There are also many drugs used to treat the secondary symptoms of MS (i.e., fatigue, spasticity, bladder or bowel
Facts.
Diagnosis.